GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$4.33M
Contract actions61
Awards / PIIDs40
Federal customers3
Contracting offices12
Average action$70.9K
Active fiscal years7
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $4.33M in net contract obligations to GEMINI BIOPRODUCTS, LLC across 61 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

GEMINI BIOPRODUCTS, LLC contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$63.5K
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$63.3K21
FY 2020$3.72M112+5,767.6%
FY 2021$277.8K202−92.5%
FY 2022$23.1K71−91.7%
FY 2023$43.2K151+86.7%
FY 2024$141.0K41+226.5%
FY 2025$63.5K21−55.0%

04 / Federal Customers

Which federal agencies buy from GEMINI BIOPRODUCTS, LLC?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
7022$3.66M384.6%
7529$595.2K5313.8%
12K3$72.8K51.7%

05 / Contracting Offices

Which contracting offices buy from GEMINI BIOPRODUCTS, LLC?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
339112SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING$3.66M3184.6%
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$668.4K57215.4%
325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING-$472110.0%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$3.66M3184.6%
6505DRUGS AND BIOLOGICALS$277.4K3916.4%
6640LABORATORY EQUIPMENT AND SUPPLIES$262.5K1226.1%
6509DRUGS AND BIOLOGICALS, VETERINARY USE$66.5K521.5%
6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$61.5K211.4%

08 / Competition Pattern

How was GEMINI BIOPRODUCTS, LLC’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Competed under SAP$243.0K33
Other / unknown$402.0K19
Not available for competition$23.0K6
Not competed under SAP$3.66M3

09 / Recent Contract Awards

What contract actions were recorded most recently for GEMINI BIOPRODUCTS, LLC?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75N92B20F00001Mar 27, 2025-$64NATIONAL INSTITUTES OF HEALTH NIH NIAMS3254146505

10 / Interpreting the Profile

How should you evaluate GEMINI BIOPRODUCTS, LLC as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.